4D Molecular Therapeutics...

NASDAQ: FDMT · Real-Time Price · USD
4.36
0.45 (11.51%)
At close: Jun 06, 2025, 3:59 PM
4.20
-3.56%
After-hours: Jun 06, 2025, 04:27 PM EDT

4D Molecular Therapeutics Statistics

Share Statistics

4D Molecular Therapeutics has 46.32M shares outstanding. The number of shares has increased by -10.45% in one year.

46.32M
-10.45%
0.16%
84.35%
n/a
3,720
0.6%

Short Selling Information

The latest short interest is 4.67M, so 10.08% of the outstanding shares have been sold short.

4.67M
10.08%
10.49%
9.03

Valuation Ratios

The PE ratio is -1.87 and the forward PE ratio is -0.99. 4D Molecular Therapeutics's PEG ratio is -0.12.

-1.87
-0.99
8120.72
1.4
0.59
-2.17
-0.12
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for 4D Molecular Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 14.92, with a Debt / Equity ratio of 0.05.

14.92
14.92
0.05
-0.13
-0.18
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$163
$-708,669.6
227
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -82.81% in the last 52 weeks. The beta is 2.83, so 4D Molecular Therapeutics's price volatility has been higher than the market average.

2.83
-82.81%
3.3
6.84
60.35
616,876

Income Statement

In the last 12 months, 4D Molecular Therapeutics had revenue of 37K and earned -160.87M in profits. Earnings per share was -2.98.

37K
37K
-187.84M
-160.87M
-187.84M
-187.84M
-2.98
Full Income Statement

Balance Sheet

The company has 149.34M in cash and 24.61M in debt, giving a net cash position of 124.73M.

149.34M
24.61M
124.73M
-576.2M
515.73M
305.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -134.59M and capital expenditures -3.79M, giving a free cash flow of -138.37M.

-134.59M
-3.79M
-138.37M
-2.57
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -507678.38% and -434778.38%.

100%
-507678.38%
-434778.38%
-434778.38%
-507678.38%
-507678.38%
-373975.68%

Dividends & Yields

FDMT does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for FDMT is $37, which is 853.6% higher than the current price. The consensus rating is "Buy".

$37
853.6%
Buy
10
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-0.19
2